BUBR1 and MAD2: Novel Markers for Predicting Benefit from Adjuvant Anthracyclines?

A. F. Munro, D. A. Cameron, James Thomas, C. J. Twelves, J. M. S. Bartlett

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)632S-633S
Number of pages2
JournalCancer Research
Issue number24
Publication statusPublished - 15 Dec 2009

Cite this